Why SPRY? ARS Pharmaceuticals, Inc. Analysis, Price & AI Insights | Whystock
SPRY
$8.56+0.30 (+3.63%)
Market ClosedLast close May 1
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.